RecruitingNCT06410976

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Studying Hypochondroplasia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: QED Therapeutics, a BridgeBio company
Enrollment: 150 enrolled
Eligibility: 16 years · All sexes
Timeline: 2024 – 2026

Study locations (25)

UCSF Benioff Children's Hospital, Oakland, California, United States
Childrens Hospital Colorado, Aurora, Colorado, United States
Children's National Hospital, Washington D.C., District of Columbia, United States
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
University of Missouri, Columbia, Missouri, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison, Wisconsin, United States
Murdoch Children's Research Institute, Parkville, Victoria, Australia
London Health Sciences Centre - Children's Hospital of Western Ontario, London, Ontario, Canada
Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada
Hôpital Femme Mère Enfant HCL, Bron, France
Hôpital Necker-Enfants Malades, Paris, France
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse, France
+10 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06410976 on ClinicalTrials.gov

Other trials for Hypochondroplasia

Additional recruiting or active studies for the same condition.

See all trials for Hypochondroplasia →

← Back to all trials